Interprofessional Pharmacogenomics (IPGx) Registry and Repository

Recruiting · NCT06726590 · Observational (researchers observe without assigning treatment) · Lead sponsor: Texas A&M University

What this trial is about

This program collects genetic and health information to help doctors choose the right medications for patients.

Age range

18 Years and older

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not specified

Study type

Observational (researchers observe without assigning treatment)

The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or
Individuals taking blood pressure or depression medications, even if less than five medications.
Ability to understand and give consent.
Able to consent to donate blood and/or urine samples and buccal swabs.
Able to answer detailed questionnaires, including quarterly questionnaires about ADRs, cognitive testing such as serial mini-mental status exams, and or quality of life questions.
Able to understand that their health record and changes in health status will be followed for a five-year period and shared in deidentified form with the research community.
All genders.
Any age over 18 years.

Individuals admitted to hospice.
Declines to participate or interact with staff/share their medical status.
A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning.,
Individuals who are unable or unwilling to provide consent.
Unable to verbally communicate and comprehend English language

1 location listed across 1 US state.